A Study of SRSD216 in Patients With Elevated Lipoprotein (a)

NCT07172646 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipoproteinemia (a)

Interventions

DRUG: SRSD216 injection
DRUG: Placebo

Sponsor

Sirius Therapeutics Co., Ltd.